Based on the forecast data for the import of Phenazone (Antipyrin) to Canada, the expected growth from 2024 to 2028 signals a steady increase in import value. Starting from a base of approximately $602.11 thousand in 2024, the value is projected to rise to $707.03 thousand by 2028. This increment marks an average annual growth rate, reflecting a consistent upward trend.

Future trends to monitor include:

Potential changes in Canada’s healthcare market demand for Phenazone and substitutes.
Economic factors affecting import costs and pricing.
Regulatory changes impacting pharmaceutical imports.
Technological advancements or innovations that may influence the market.